These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38718215)
1. Drug Crystal Precipitation in Biorelevant Bicarbonate Buffer: A Well-Controlled Comparative Study with Phosphate Buffer. Yamamoto H; Sugano K Mol Pharm; 2024 Jun; 21(6):2854-2864. PubMed ID: 38718215 [TBL] [Abstract][Full Text] [Related]
2. Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer. Okamoto N; Higashino M; Yamamoto H; Sugano K Pharm Res; 2024 May; 41(5):959-966. PubMed ID: 38653942 [TBL] [Abstract][Full Text] [Related]
3. Dissolution Profiles of Poorly Soluble Drug Salts in Bicarbonate Buffer. Sakamoto A; Sugano K Pharm Res; 2023 Apr; 40(4):989-998. PubMed ID: 37024757 [TBL] [Abstract][Full Text] [Related]
4. Dissolution Kinetics of Nifedipine-Ionizable Polymer Amorphous Solid Dispersion: Comparison Between Bicarbonate and Phosphate Buffers. Sakamoto A; Sugano K Pharm Res; 2021 Dec; 38(12):2119-2127. PubMed ID: 34931285 [TBL] [Abstract][Full Text] [Related]
5. In Vivo Predictive Dissolution: Comparing the Effect of Bicarbonate and Phosphate Buffer on the Dissolution of Weak Acids and Weak Bases. Krieg BJ; Taghavi SM; Amidon GL; Amidon GE J Pharm Sci; 2015 Sep; 104(9):2894-904. PubMed ID: 25980464 [TBL] [Abstract][Full Text] [Related]
6. Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel. Salehi N; Al-Gousous J; Mudie DM; Amidon GL; Ziff RM; Amidon GE Mol Pharm; 2020 Oct; 17(10):3870-3884. PubMed ID: 32886520 [TBL] [Abstract][Full Text] [Related]
7. Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs. McNamara DP; Whitney KM; Goss SL Pharm Res; 2003 Oct; 20(10):1641-6. PubMed ID: 14620520 [TBL] [Abstract][Full Text] [Related]
8. Improved Prediction of in Vivo Supersaturation and Precipitation of Poorly Soluble Weakly Basic Drugs Using a Biorelevant Bicarbonate Buffer in a Gastrointestinal Transfer Model. Jede C; Wagner C; Kubas H; Weigandt M; Weber C; Lecomte M; Badolo L; Koziolek M; Weitschies W Mol Pharm; 2019 Sep; 16(9):3938-3947. PubMed ID: 31335153 [TBL] [Abstract][Full Text] [Related]
9. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer. Amaral Silva D; Al-Gousous J; Davies NM; Bou Chacra N; Webster GK; Lipka E; Amidon G; Löbenberg R Eur J Pharm Biopharm; 2019 Sep; 142():8-19. PubMed ID: 31195131 [TBL] [Abstract][Full Text] [Related]
10. A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds. Garbacz G; Kołodziej B; Koziolek M; Weitschies W; Klein S Eur J Pharm Sci; 2014 Jan; 51():224-31. PubMed ID: 24095865 [TBL] [Abstract][Full Text] [Related]
12. Dissolution of a Biopharmaceutics Classification System Class II Free Acid from Immediate Release Tablets Containing a Microenvironmental pH Modulator: Comparison of a Biorelevant Bicarbonate Buffering System with Phosphate Buffers. Haznar-Garbacz D; Hoc D; Garbacz G; Lachman M; Słomińska D; Romański M AAPS PharmSciTech; 2022 Jul; 23(6):203. PubMed ID: 35882674 [TBL] [Abstract][Full Text] [Related]
13. The effect of buffer species on biorelevant dissolution and precipitation assays - Comparison of phosphate and bicarbonate buffer. Krollik K; Lehmann A; Wagner C; Kaidas J; Kubas H; Weitschies W Eur J Pharm Biopharm; 2022 Feb; 171():90-101. PubMed ID: 34592364 [TBL] [Abstract][Full Text] [Related]
14. Phosphate buffer interferes dissolution of prazosin hydrochloride in compendial dissolution testing. Sudaki H; Fujimoto K; Wada K; Sugano K Drug Metab Pharmacokinet; 2023 Aug; 51():100519. PubMed ID: 37393739 [TBL] [Abstract][Full Text] [Related]
15. Is bicarbonate buffer suitable as a dissolution medium? Boni JE; Brickl RS; Dressman J J Pharm Pharmacol; 2007 Oct; 59(10):1375-82. PubMed ID: 17910812 [TBL] [Abstract][Full Text] [Related]
16. Matching phosphate and maleate buffer systems for dissolution of weak acids: Equivalence in terms of buffer capacity of bulk solution or surface pH? Cristofoletti R; Dressman JB Eur J Pharm Biopharm; 2016 Jun; 103():104-108. PubMed ID: 27032508 [TBL] [Abstract][Full Text] [Related]
17. Effect of initial buffer composition on pH changes during far-from-equilibrium freezing of sodium phosphate buffer solutions. Gómez G; Pikal MJ; Rodríguez-Hornedo N Pharm Res; 2001 Jan; 18(1):90-7. PubMed ID: 11336359 [TBL] [Abstract][Full Text] [Related]
18. Mechanistic understanding of underperforming enteric coated products: Opportunities to add clinical relevance to the dissolution test. Amaral Silva D; Davies NM; Doschak MR; Al-Gousous J; Bou-Chacra N; Löbenberg R J Control Release; 2020 Sep; 325():323-334. PubMed ID: 32649973 [TBL] [Abstract][Full Text] [Related]
19. Solubility-pH profile of desipramine hydrochloride in saline phosphate buffer: Enhanced solubility due to drug-buffer aggregates. Marković OS; Pešić MP; Shah AV; Serajuddin ATM; Verbić TŽ; Avdeef A Eur J Pharm Sci; 2019 May; 133():264-274. PubMed ID: 30914359 [TBL] [Abstract][Full Text] [Related]
20. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release. Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]